Shockwave Medical Insiders
SWAVDelisted Stock | USD 268.45 6.44 2.34% |
Shockwave Medical employs about 1.5 K people. The company is managed by 17 executives with a total tenure of roughly 16 years, averaging almost 0.0 years of service per executive, having 86.35 employees per reported executive. Recap of Shockwave Medical's management performance can provide insight into the venture performance.
Shockwave |
Shockwave Medical Management Team Effectiveness
The company has return on total asset (ROA) of 0.0868 % which means that it generated a profit of $0.0868 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.2473 %, meaning that it created $0.2473 on every $100 dollars invested by stockholders. Shockwave Medical's management efficiency ratios could be used to measure how well Shockwave Medical manages its routine affairs as well as how well it operates its assets and liabilities.Shockwave Medical Workforce Comparison
Shockwave Medical is rated below average in number of employees category among its peers. The total workforce of Health Care industry is at this time estimated at about 121,340. Shockwave Medical claims roughly 1,468 in number of employees contributing just under 2% to equities under Health Care industry.
The company has Profit Margin (PM) of 0.21 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.19 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.19. Shockwave Medical Insider Trading
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Shockwave Medical insiders, such as employees or executives, is commonly permitted as long as it does not rely on Shockwave Medical's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Shockwave Medical insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Godshall Douglas Evan over six months ago Disposition of 100810 shares by Godshall Douglas Evan of Shockwave Medical subject to Rule 16b-3 | ||
Trinh Phung over six months ago Disposition of 16033 shares by Trinh Phung of Shockwave Medical at 6.71 subject to Rule 16b-3 | ||
Renee Gaeta over six months ago Insider Trading | ||
Trinh Phung over six months ago Disposition of 215 shares by Trinh Phung of Shockwave Medical at 329.81 subject to Rule 16b-3 | ||
Francis Laura over six months ago Disposition of 1500 shares by Francis Laura of Shockwave Medical at 300.0 subject to Rule 16b-3 | ||
Godshall Douglas Evan over six months ago Disposition of 1987 shares by Godshall Douglas Evan of Shockwave Medical at 231.74 subject to Rule 16b-3 | ||
Isaac Zacharias over six months ago Acquisition by Isaac Zacharias of 9395 shares of Shockwave Medical subject to Rule 16b-3 | ||
Isaac Zacharias over six months ago Acquisition by Isaac Zacharias of 7506 shares of Shockwave Medical subject to Rule 16b-3 |
Shockwave Medical Notable Stakeholders
A Shockwave Medical stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Shockwave Medical often face trade-offs trying to please all of them. Shockwave Medical's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Shockwave Medical's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
John Adams | CoFounder Advisor | Profile | |
Daniel Hawkins | Founder Advisor | Profile | |
Douglas MBA | CEO President | Profile | |
Isaac Zacharias | Chief Officer | Profile | |
Debbie Kaster | Vice Relations | Profile | |
FACC FRCP | Chief Officer | Profile | |
Rob Williamson | VP Sales | Profile | |
Cathy Harnett | Senior Resources | Profile | |
Hajime JD | General Secretary | Profile | |
Patrick Stephens | Senior Development | Profile | |
Renee Gaeta | Chief Officer | Profile | |
Daniel MBA | Principal CFO | Profile | |
Mike Maszy | VP Operations | Profile | |
Trinh Phung | Principal Officer | Profile | |
Robert Fletcher | Senior Access | Profile | |
Luis Morales | Senior Operations | Profile | |
Dave Cox | Vice Sales | Profile |
About Shockwave Medical Management Performance
The success or failure of an entity such as Shockwave Medical often depends on how effective the management is. Shockwave Medical management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Shockwave management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Shockwave management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
ShockWave Medical, Inc., a medical device company, engages in developing and commercializing intravascular lithotripsy technology for the treatment of calcified plaque in patients with peripheral vascular, coronary vascular, and heart valve diseases worldwide. The company was incorporated in 2009 and is headquartered in Santa Clara, California. Shockwave Medical operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 657 people.
Please note, the imprecision that can be found in Shockwave Medical's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Shockwave Medical. Check Shockwave Medical's Beneish M Score to see the likelihood of Shockwave Medical's management manipulating its earnings.
Shockwave Medical Workforce Analysis
Traditionally, organizations such as Shockwave Medical use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Shockwave Medical within its industry.Shockwave Medical Manpower Efficiency
Return on Shockwave Medical Manpower
Revenue Per Employee | 497.4K | |
Revenue Per Executive | 43M | |
Net Income Per Employee | 100.3K | |
Net Income Per Executive | 8.7M | |
Working Capital Per Employee | 763.7K | |
Working Capital Per Executive | 65.9M |
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.
Other Consideration for investing in Shockwave Stock
If you are still planning to invest in Shockwave Medical check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Shockwave Medical's history and understand the potential risks before investing.
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm |